doi: 10.1038/4571064a.
Drug patent plan gets mixed reviews
- PMID: 19256077
- DOI: 10.1038/4571064a
Item in Clipboard
Drug patent plan gets mixed reviews
Nature.
.
No abstract available
Similar articles
-
A new era of hope for the world's most neglected diseases.PLoS Med. 2005 Sep;2(9):e323. doi: 10.1371/journal.pmed.0020323. Epub 2005 Sep 8. PLoS Med. 2005. PMID: 16138790 Free PMC article.
-
Jumpstarting research into neglected diseases.Cell. 2006 Nov 3;127(3):443-5. doi: 10.1016/j.cell.2006.10.022. Cell. 2006. PMID: 17081963
-
Small biotechs raring to cash in on the orphan disease market.Nat Med. 2012 Mar 6;18(3):330-1. doi: 10.1038/nm0312-330. Nat Med. 2012. PMID: 22395682 No abstract available.
-
[Cohorts and registers: Which public/private partnerships to choose?].Presse Med. 2012 May;41 Suppl 1:S15-9. doi: 10.1016/j.lpm.2012.02.023. Epub 2012 Mar 30. Presse Med. 2012. PMID: 22464892 French. No abstract available.
-
Should the patent system for pharmaceuticals be replaced? A theoretical approach.Expert Rev Pharmacoecon Outcomes Res. 2014 Oct;14(5):617-26. doi: 10.1586/14737167.2014.927315. Epub 2014 Jun 17. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 24934980 Review.
Cited by
-
The UNITAID Patent Pool Initiative: Bringing Patents Together for the Common Good.Open AIDS J. 2010 Jan 19;4:37-40. doi: 10.2174/1874613601004020037. Open AIDS J. 2010. PMID: 20309404 Free PMC article.
-
Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery.Nat Rev Drug Discov. 2009 Sep;8(9):701-8. doi: 10.1038/nrd2944. Epub 2009 Jul 17. Nat Rev Drug Discov. 2009. PMID: 19609266 Review.
-
Drug Discovery in Academia- the third way?Expert Opin Drug Discov. 2010 Oct 1;5(10):909-19. doi: 10.1517/17460441.2010.506508. Expert Opin Drug Discov. 2010. PMID: 20922062 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
